Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Guardant Health Inc - SIC # 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
GH
Nasdaq
2835
https://guardanthealth.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Guardant Health Inc
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
- Apr 22nd, 2024 1:00 pm
FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23
- Apr 22nd, 2024 12:52 pm
Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024
- Apr 18th, 2024 8:05 pm
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting
- Apr 3rd, 2024 12:05 pm
Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales
- Apr 2nd, 2024 8:02 pm
Better Than ChatGPT? New Super AI Bot Says Buy These 3 Stocks.
- Apr 1st, 2024 12:35 pm
20 Foods To Reduce Cancer Risk
- Mar 30th, 2024 11:43 pm
A blood test for colon cancer performed well in a study, expanding options for screening
- Mar 13th, 2024 9:09 pm
Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine
- Mar 13th, 2024 9:00 pm
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mar 6th, 2024 9:30 pm
New Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap
- Mar 1st, 2024 10:30 am
21 Countries that Have the Highest Rates of Cancer Deaths
- Feb 28th, 2024 11:46 pm
Guardant Health, Inc. (NASDAQ:GH) Q4 2023 Earnings Call Transcript
- Feb 23rd, 2024 4:48 pm
Guardant Health Insiders Added US$5.05m Of Stock To Their Holdings
- Feb 23rd, 2024 2:24 pm
Guardant Health (GH) Reports Q4 Earnings: What Key Metrics Have to Say
- Feb 23rd, 2024 12:00 am
Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates
- Feb 22nd, 2024 11:20 pm
Guardant Health Inc (GH) Reports 25% Revenue Growth in Full Year 2023
- Feb 22nd, 2024 9:38 pm
Guardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
- Feb 22nd, 2024 9:05 pm
Wall Street Analysts Think Guardant Health (GH) Could Surge 109.89%: Read This Before Placing a Bet
- Feb 22nd, 2024 2:55 pm
15 Best Hospitals for Cancer Treatment in the US
- Feb 16th, 2024 8:10 am
Scroll